BAFF-R activators belong to a specialized category of chemical agents designed to modulate the activity of the B-cell activating factor receptor, also known as BAFF-R or BR3. BAFF-R is a cell surface receptor that is predominantly expressed on B cells and is part of the TNF receptor superfamily. The activation of BAFF-R is an important event in the regulation of B cell development, maturation, and survival. Chemicals that activate BAFF-R typically mimic or enhance the action of its natural ligand, the B-cell activating factor (BAFF), a cytokine that engages with BAFF-R to influence B cell biology. The interaction between BAFF and BAFF-R is a key component in maintaining the balance within the B cell population, including transitional and mature B cell subsets. BAFF-R activators are designed to modulate this interaction at a molecular level.
The structure and function of BAFF-R activators are intricately linked to the molecular signaling pathways that are initiated upon receptor engagement. These activators may bind to the extracellular domain of BAFF-R, inducing oligomerization of the receptor or stabilizing its active form to promote signal transduction. The signaling cascade triggered by BAFF-R activation involves the non-canonical NF-κB pathway, which plays a significant role in B cell homeostasis. By interacting with BAFF-R, these activators can induce various intracellular responses that mirror those initiated by BAFF itself. Understanding the precise nature of BAFF-R activation by these compounds requires a deep knowledge of the receptor's structure, the conformational changes upon binding, and the subsequent activation of downstream signaling molecules.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Enhances T cell and natural killer (NK) cell activity, potentially altering the immune environment and indirectly affecting BAFF-R signaling in B cells. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Modulates the immune response and might indirectly influence BAFF-R activity through its effects on the immune system. | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $143.00 $312.00 $468.00 $1248.00 $1997.00 | 1 | |
An immunomodulatory drug that can potentially affect BAFF-R signaling indirectly through its action on immune cells. | ||||||